UMBILICAL TISSUE COMPOSITIONS AND METHODS OF USE

Disclosed are compositions comprising umbilical tissue, wherein the umbilical tissue comprises one or more engineered channels. Also disclosed are compositions comprising a previously cryopreserved umbilical tissue, wherein after cryopreservation and subsequent thawing the umbilical tissue comprises...

Full description

Saved in:
Bibliographic Details
Main Authors LERCH, Anne, KUANG, Jin-Qiang, DUAN-ARNOLD, Yi, MOORMAN, Matthew, DANILKOVITCH, Alla
Format Patent
LanguageEnglish
French
German
Published 24.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are compositions comprising umbilical tissue, wherein the umbilical tissue comprises one or more engineered channels. Also disclosed are compositions comprising a previously cryopreserved umbilical tissue, wherein after cryopreservation and subsequent thawing the umbilical tissue comprises: a) viable cells native to the umbilical tissue; b) tissue integrity of native umbilical tissue; c) one or more growth factors that are native to the umbilical tissue; and d) depleted amounts of one or more types of functional immunogenic cells. Disclosed are methods of producing compositions comprising umbilical tissue, wherein the umbilical tissue comprises one or more engineered channels. Also disclosed are methods of treating damaged tissue comprising administering to the site of the damaged tissue compositions comprising umbilical tissue, wherein the umbilical tissue comprises one or more engineered channels.
Bibliography:Application Number: EP20160849682